Editing human hematopoietic stem cells: advances and challenges

被引：8
作者：
Bhoopalan, Senthil Velan [1 ,2 ]
Yen, Jonathan S. [1 ]
Levine, Rachel M. [1 ]
Sharma, Akshay [2 ,3 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, Memphis, TN USA
[3] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 262 Danny Thomas Pl, MS1130, Memphis, TN 38105 USA
来源：
CYTOTHERAPY | 2023年 / 25卷 / 03期
关键词：
CRISPR-Cas9; hematopoietic stem cells; severe congenital neutropenia; sickle cell disease; GENE-THERAPY; ALPHA-GLOBIN; BASE EDITORS; GENOMIC DNA; TARGET; RNA; CAS9; SPECIFICITIES; COLLECTION; NUCLEASES;
D O I：
10.1016/j.jcyt.2022.08.003
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Genome editing of hematopoietic stem and progenitor cells is being developed for the treatment of several inherited disorders of the hematopoietic system. The adaptation of CRISPR-Cas9-based technologies to make precise CHANGES TO THE GENOME, and developments in altering the specificity and efficiency, and improving the delivery of nucleases to target cells have led to several breakthroughs. Many clinical trials are ongoing, and several pre-clinical models have been reported that would allow these genetic therapies to one day offer a potential cure to patients with diseases where limited options currently exist. However, there remain several challenges with respect to establishing safety, expanding accessibility and improving the manufacturing pro -cesses of these therapeutic products. This review focuses on some of the recent advances in the field of genome editing of hematopoietic stem and progenitor cells and illustrates the ongoing challenges.(c) 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：261 / 269
页数：9
相关论文
共 135 条
  • [1] A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action
    Abadi, Shiran
    Yan, Winston X.
    Amar, David
    Mayrose, Itay
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (10)
  • [2] Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template
    Aird, Eric J.
    Lovendahl, Klaus N.
    St Martin, Amber
    Harris, Reuben S.
    Gordon, Wendy R.
    [J]. COMMUNICATIONS BIOLOGY, 2018, 1
  • [3] [Anonymous], ALLOGENE THERAPEUTIC
  • [4] Search-and-replace genome editing without double-strand breaks or donor DNA
    Anzalone, Andrew V.
    Randolph, Peyton B.
    Davis, Jessie R.
    Sousa, Alexander A.
    Koblan, Luke W.
    Levy, Jonathan M.
    Chen, Peter J.
    Wilson, Christopher
    Newby, Gregory A.
    Raguram, Aditya
    Liu, David R.
    [J]. NATURE, 2019, 576 (7785) : 149 - +
  • [5] Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
    Bae, Sangsu
    Park, Jeongbin
    Kim, Jin-Soo
    [J]. BIOINFORMATICS, 2014, 30 (10) : 1473 - 1475
  • [6] Ex Vivo Expansion of CD34+CD90+CD49f+ Hematopoietic Stem and Progenitor Cells from Non-Enriched Umbilical Cord Blood with Azole Compounds
    Bari, Sudipto
    Zhong, Qixing
    Fan, Xiubo
    Poon, Zhiyong
    Lim, Alvin Soon Tiong
    Lim, Tse Hui
    Dighe, Niraja
    Li, Shang
    Chiu, Gigi Ngar Chee
    Chai, Christina Li Lin
    Hwang, William Ying Khee
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (05) : 376 - 393
  • [7] megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering
    Boissel, Sandrine
    Jarjour, Jordan
    Astrakhan, Alexander
    Adey, Andrew
    Gouble, Agnes
    Duchateau, Philippe
    Shendure, Jay
    Stoddard, Barry L.
    Certo, Michael T.
    Baker, David
    Scharenberg, Andrew M.
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (04) : 2591 - 2601
  • [8] Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9
    Byambaa, Suvd
    Uosaki, Hideki
    Ohmori, Tsukasa
    Hara, Hiromasa
    Endo, Hitoshi
    Nureki, Osamu
    Hanazono, Yutaka
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 451 - 462
  • [9] Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
    Chaudhari, Hemangi G.
    Penterman, Jon
    Whitton, Holly J.
    Spencer, Sarah J.
    Flanagan, Nicole
    Zhang, Maria C. Lei
    Huang, Elaine
    Khedkar, Aditya S.
    Toomey, J. Mike
    Shearer, Courtney A.
    Needham, Alexander W.
    Ho, Tony W.
    Kulman, John D.
    Cradick, T. J.
    Kernytsky, Andrew
    [J]. CRISPR JOURNAL, 2020, 3 (06): : 440 - 453
  • [10] Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
    Chen, Peter J.
    Hussmann, Jeffrey A.
    Yan, Jun
    Knipping, Friederike
    Ravisankar, Purnima
    Chen, Pin-Fang
    Chen, Cidi
    Nelson, James W.
    Newby, Gregory A.
    Sahin, Mustafa
    Osborn, Mark J.
    Weissman, Jonathan S.
    Adamson, Britt
    Liu, David R.
    [J]. CELL, 2021, 184 (22) : 5635 - +
12345678910